These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9178474)

  • 21. Thoughts on vaccination protocols.
    Petzel B
    J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
    [No Abstract]   [Full Text] [Related]  

  • 22. MT-PCR panel detection of canine parvovirus (CPV-2): Vaccine and wild-type CPV-2 can be difficult to differentiate in canine diagnostic fecal samples.
    Meggiolaro MN; Ly A; Rysnik-Steck B; Silva C; Zhang J; Higgins DP; Muscatello G; Norris JM; Krockenberger M; Šlapeta J
    Mol Cell Probes; 2017 Jun; 33():20-23. PubMed ID: 28254505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
    Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
    New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
    Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
    Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration with Vaccinia Virus Encoding Canine Parvovirus 2
    Zhao W; Wang X; Li Y; Li Y
    Viral Immunol; 2020; 33(6):434-443. PubMed ID: 32364832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination.
    Decaro N; Crescenzo G; Desario C; Cavalli A; Losurdo M; Colaianni ML; Ventrella G; Rizzi S; Aulicino S; Lucente MS; Buonavoglia C
    Vaccine; 2014 Jun; 32(30):3850-3. PubMed ID: 24793948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous feline retrovirus RD-114 does not elicit neutralizing antibodies in dogs.
    Narushima R; Ogawa T; Shimazaki T
    Acta Virol; 2012; 56(4):343-4. PubMed ID: 23237091
    [No Abstract]   [Full Text] [Related]  

  • 30. Thoughts on vaccination protocols.
    McLaughlin MA
    J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
    [No Abstract]   [Full Text] [Related]  

  • 31. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canine parvovirus vaccination.
    Atkinson M
    Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
    [No Abstract]   [Full Text] [Related]  

  • 34. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
    Altman KD; Kelman M; Ward MP
    Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of immune status in dogs against CPV-2 by recombinant protein based latex agglutination test.
    Thomas J; Singh M; Goswami TK; Glora P; Chakravarti S; Chander V; Upmanyu V; Verma S; Sharma C; Mahendran K
    Biologicals; 2017 Sep; 49():51-56. PubMed ID: 28689674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of canine IL-2 and IL-7 genes on enhancing immunogenicity of canine parvovirus VP2 gene vaccine in mice].
    Chen H; Zhong F; Li X; Wang L; Sun Y; Neng C; Zhang K; Li W; Wen J
    Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1392-9. PubMed ID: 23383511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
    Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
    Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.